{"id":"NCT01880320","sponsor":"Galderma R&D","briefTitle":"Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris","officialTitle":"A Multi-center, Randomized, Double-blind, Parallel-group Vehicle and Active Controlled Study to Compare the Efficacy and Safety of CD0271 0.3% / CD1579 2.5% Topical Gel Versus Topical Gel Vehicle in Subjects With Acne Vulgaris","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-07","primaryCompletion":"2014-03","completion":"2014-03","firstPosted":"2013-06-18","resultsPosted":"2016-09-09","lastUpdate":"2018-06-28"},"enrollment":503,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Acne Vulgaris"],"interventions":[{"type":"DRUG","name":"CD0271 0.3% / CD1579 2.5%","otherNames":[]},{"type":"DRUG","name":"CD0271 0.1% / CD1579 2.5%","otherNames":[]},{"type":"DRUG","name":"Topical Gel Vehicle","otherNames":[]}],"arms":[{"label":"CD0271 0.3% /CD1579 2.5% Gel","type":"EXPERIMENTAL"},{"label":"CD0271 0.1% / CD1579 2.5%","type":"ACTIVE_COMPARATOR"},{"label":"Topical Gel Vehicle","type":"PLACEBO_COMPARATOR"}],"summary":"The study hypothesis are based on the assumption that :\n\n* CD0271 0.3%/CD1579 2.5% Gel provides superior clinical efficacy compared with Topical Gel Vehicle in the overall population and in the subgroup of severe Subjects\n* CD0271 0.3%/CD1579 2.5% Gel applied once daily for up to 12 weeks has an acceptable safety and tolerability profile","primaryOutcome":{"measure":"Success Rate","timeFrame":"Week 12","effectByArm":[{"arm":"CD0271 0.3% /CD1579 2.5% Gel","deltaMin":33.7,"sd":null},{"arm":"CD0271 0.1% / CD1579 2.5%","deltaMin":27.3,"sd":null},{"arm":"Topical Gel Vehicle","deltaMin":11,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":31,"countries":["United States","Canada"]},"refs":{"pmids":["28686776","28686775","26945741"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":217},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Skin irritation","Headache","Infleunza"]}}